MAD (multiagent delivery) nanolayer: Delivering multiple therapeutics from hierarchically assembled surface coatings

Byeong-Su Kim, Renée C. Smith, Zhiyong Poon, Paula T. Hammond

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

We present hydrolytically degradable polymeric multilayer films that can codeliver multiple therapeutics of differing chemical characteristics (charged biomacromolecules and neutral hydrophobic small molecules) from a surface. This multiagent-delivery (MAD) nanolayer system integrates the hydrolytically degradable poly(β-amino ester) as a structural component to control the degradation of the multilayers to release active therapeutic macromolecules as well as hydrophobic drugs imbedded within amphiphilic block copolymer micellar carriers within layer-by-layer (LbL) films, which would otherwise be difficult to include within the multilayers. By varying the anionic therapeutic agents (heparin and dextran sulfate) within the multilayer, we examine how different structural components can be used to control the release kinetics of multiple therapeutics from MAD nanolayers. Controlled release profiles and the in vitro efficacy of the MAD nanolayers in suppressing the growth of human smooth muscle cell lines were evaluated. The dual delivery of a charged macromolecular heparin and a small hydrophobic drug, paclitaxel, is found to be synergistic and beneficial toward effective therapeutic activity. Furthermore, we compared the classical dipping method that we employed here with an automated spray-LbL technique. Spray-LbL significantly facilitates film processing time while preserving the characteristic release profiles of the MAD nanolayers. With the highly versatile and tunable nature of LbL assembly, we anticipate that MAD nanolayers can provide a unique platform for delivering multiple therapeutics from macromolecules to small molecules with distinct release profiles for applications in biological and biomedical surface coatings.

Original languageEnglish
Pages (from-to)14086-14092
Number of pages7
JournalLangmuir
Volume25
Issue number24
DOIs
Publication statusPublished - 2009 Dec 15

Fingerprint

delivery
Multilayers
Macromolecules
coatings
Coatings
Heparin
Dextran Sulfate
Molecules
Dextran
Multilayer films
heparins
Paclitaxel
Polymer films
Pharmaceutical Preparations
Block copolymers
Muscle
Esters
Cells
macromolecules
sprayers

All Science Journal Classification (ASJC) codes

  • Materials Science(all)
  • Condensed Matter Physics
  • Surfaces and Interfaces
  • Spectroscopy
  • Electrochemistry

Cite this

Kim, Byeong-Su ; Smith, Renée C. ; Poon, Zhiyong ; Hammond, Paula T. / MAD (multiagent delivery) nanolayer : Delivering multiple therapeutics from hierarchically assembled surface coatings. In: Langmuir. 2009 ; Vol. 25, No. 24. pp. 14086-14092.
@article{7c01e91a9eb9471883b0f73ccb126254,
title = "MAD (multiagent delivery) nanolayer: Delivering multiple therapeutics from hierarchically assembled surface coatings",
abstract = "We present hydrolytically degradable polymeric multilayer films that can codeliver multiple therapeutics of differing chemical characteristics (charged biomacromolecules and neutral hydrophobic small molecules) from a surface. This multiagent-delivery (MAD) nanolayer system integrates the hydrolytically degradable poly(β-amino ester) as a structural component to control the degradation of the multilayers to release active therapeutic macromolecules as well as hydrophobic drugs imbedded within amphiphilic block copolymer micellar carriers within layer-by-layer (LbL) films, which would otherwise be difficult to include within the multilayers. By varying the anionic therapeutic agents (heparin and dextran sulfate) within the multilayer, we examine how different structural components can be used to control the release kinetics of multiple therapeutics from MAD nanolayers. Controlled release profiles and the in vitro efficacy of the MAD nanolayers in suppressing the growth of human smooth muscle cell lines were evaluated. The dual delivery of a charged macromolecular heparin and a small hydrophobic drug, paclitaxel, is found to be synergistic and beneficial toward effective therapeutic activity. Furthermore, we compared the classical dipping method that we employed here with an automated spray-LbL technique. Spray-LbL significantly facilitates film processing time while preserving the characteristic release profiles of the MAD nanolayers. With the highly versatile and tunable nature of LbL assembly, we anticipate that MAD nanolayers can provide a unique platform for delivering multiple therapeutics from macromolecules to small molecules with distinct release profiles for applications in biological and biomedical surface coatings.",
author = "Byeong-Su Kim and Smith, {Ren{\'e}e C.} and Zhiyong Poon and Hammond, {Paula T.}",
year = "2009",
month = "12",
day = "15",
doi = "10.1021/la9017618",
language = "English",
volume = "25",
pages = "14086--14092",
journal = "Langmuir",
issn = "0743-7463",
publisher = "American Chemical Society",
number = "24",

}

MAD (multiagent delivery) nanolayer : Delivering multiple therapeutics from hierarchically assembled surface coatings. / Kim, Byeong-Su; Smith, Renée C.; Poon, Zhiyong; Hammond, Paula T.

In: Langmuir, Vol. 25, No. 24, 15.12.2009, p. 14086-14092.

Research output: Contribution to journalArticle

TY - JOUR

T1 - MAD (multiagent delivery) nanolayer

T2 - Delivering multiple therapeutics from hierarchically assembled surface coatings

AU - Kim, Byeong-Su

AU - Smith, Renée C.

AU - Poon, Zhiyong

AU - Hammond, Paula T.

PY - 2009/12/15

Y1 - 2009/12/15

N2 - We present hydrolytically degradable polymeric multilayer films that can codeliver multiple therapeutics of differing chemical characteristics (charged biomacromolecules and neutral hydrophobic small molecules) from a surface. This multiagent-delivery (MAD) nanolayer system integrates the hydrolytically degradable poly(β-amino ester) as a structural component to control the degradation of the multilayers to release active therapeutic macromolecules as well as hydrophobic drugs imbedded within amphiphilic block copolymer micellar carriers within layer-by-layer (LbL) films, which would otherwise be difficult to include within the multilayers. By varying the anionic therapeutic agents (heparin and dextran sulfate) within the multilayer, we examine how different structural components can be used to control the release kinetics of multiple therapeutics from MAD nanolayers. Controlled release profiles and the in vitro efficacy of the MAD nanolayers in suppressing the growth of human smooth muscle cell lines were evaluated. The dual delivery of a charged macromolecular heparin and a small hydrophobic drug, paclitaxel, is found to be synergistic and beneficial toward effective therapeutic activity. Furthermore, we compared the classical dipping method that we employed here with an automated spray-LbL technique. Spray-LbL significantly facilitates film processing time while preserving the characteristic release profiles of the MAD nanolayers. With the highly versatile and tunable nature of LbL assembly, we anticipate that MAD nanolayers can provide a unique platform for delivering multiple therapeutics from macromolecules to small molecules with distinct release profiles for applications in biological and biomedical surface coatings.

AB - We present hydrolytically degradable polymeric multilayer films that can codeliver multiple therapeutics of differing chemical characteristics (charged biomacromolecules and neutral hydrophobic small molecules) from a surface. This multiagent-delivery (MAD) nanolayer system integrates the hydrolytically degradable poly(β-amino ester) as a structural component to control the degradation of the multilayers to release active therapeutic macromolecules as well as hydrophobic drugs imbedded within amphiphilic block copolymer micellar carriers within layer-by-layer (LbL) films, which would otherwise be difficult to include within the multilayers. By varying the anionic therapeutic agents (heparin and dextran sulfate) within the multilayer, we examine how different structural components can be used to control the release kinetics of multiple therapeutics from MAD nanolayers. Controlled release profiles and the in vitro efficacy of the MAD nanolayers in suppressing the growth of human smooth muscle cell lines were evaluated. The dual delivery of a charged macromolecular heparin and a small hydrophobic drug, paclitaxel, is found to be synergistic and beneficial toward effective therapeutic activity. Furthermore, we compared the classical dipping method that we employed here with an automated spray-LbL technique. Spray-LbL significantly facilitates film processing time while preserving the characteristic release profiles of the MAD nanolayers. With the highly versatile and tunable nature of LbL assembly, we anticipate that MAD nanolayers can provide a unique platform for delivering multiple therapeutics from macromolecules to small molecules with distinct release profiles for applications in biological and biomedical surface coatings.

UR - http://www.scopus.com/inward/record.url?scp=74049110958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74049110958&partnerID=8YFLogxK

U2 - 10.1021/la9017618

DO - 10.1021/la9017618

M3 - Article

C2 - 19630389

AN - SCOPUS:74049110958

VL - 25

SP - 14086

EP - 14092

JO - Langmuir

JF - Langmuir

SN - 0743-7463

IS - 24

ER -